Richard Kobza

Showing 1-3 of 3 articles

Interventions for valvular disease

First-in-man implantation of the Tricento transcatheter heart valve for the treatment of severe tricuspid regurgitation

Toggweiler S, De Boeck B, Brinkert M, Buhmann R, Bossard M, Kobza R, Cuculi F

September 20, 2018 | 10.4244/EIJ-D-18-00440

Very low pacemaker rate following ACURATE neo transcatheter heart valve implantation

Toggweiler S, Nissen H, Mogensen B, Cuculi F, Fallesen C, Veien K, Brinkert M, Kobza R, Rück A

December 20, 2017 | 10.4244/EIJ-D-17-00252

Coronary interventions

A novel approach to treat in-stent restenosis: 6- and 12-month results using the everolimus-eluting bioresorbable vascular scaffold

Jamshidi P, Nyffenegger T, Sabti Z, Buset E, Toggweiler S, Kobza R, Cuculi F

April 20, 2016 | 10.4244/EIJV11I13A287

1

Latest news

Ischaemia with non-obstructive coronary arteries, OCT vs IVUS guidance in PCI; the ILUMIEN III and ILUMIEN IV trials…

January 20, 2021

The Year in Review

M. Lunardi et al

January 22, 2021

Elective Cardiac Invasive Procedures during the COVID-19 Outbreak

A. Chieffo et al.

January 8, 2021

Smoke signals – do they help to predict TAVI-associated stroke risk?

R. Kharbanda et al.

January 25, 2021

SCOPE 2, BASKET-SMALL 2 3 years, ALPHEUS, COMPARE-ABSORB, DUBIUS

(Thanks to the support of Biotronik)

January 13, 2021

Guidance Papers

Guidelines, consensus & position papers

August 28, 2020

This Week's JAA's: Redo-TAVI, Major bleeding in the Amulet Observational Study, OCT findings in ESR...

January 26, 2021

Valvular disease